We develop and protect breakthrough microbial and nanotechnology IP. All technologies are validated, scalable, and available for strategic licensing.
Explore our IP portfolio. Technologies are grouped by application area and readiness level.
Pre-optimized organisms ready for your bioprocess. Eliminate months of strain development. Genome-stable, high-yield, delivered with full performance guarantee.
Contact for Licensing DiscussionBiologically-synthesized nanoparticles with unmatched batch consistency. Narrow size distribution, stable dispersion, ready for drug delivery, sensing, or antimicrobial applications.
Contact for Licensing DiscussionProcess-ready enzymes validated for industrial conditions. High activity, thermal stability, and substrate specificity. Reduce catalyst costs by up to 60% versus chemical alternatives.
Contact for Licensing DiscussionBiodegradable, biocompatible thermoplastic granules. Drop-in replacement for conventional plastics in packaging, medical devices, and agriculture. Marine-degradable certified.
Contact for Licensing DiscussionHigh-yield hydrogen-producing consortia for waste-to-energy systems. Stable performance, minimal operational overhead, and lower capex than electrolysis at small scale.
Contact for Licensing DiscussionNovel bioactive compounds for drug discovery pipelines. Unique scaffolds not found in synthetic libraries. Supplied with purity certificate and IP-clearance documentation.
Contact for Licensing DiscussionThe IP Portfolio is our public-facing research tool. Behind it lies a network of laboratory-grade testing environments where we validate concepts, run simulations, and stress-test biological pathways before recommending them to clients.
If your research inquiry uncovers a promising direction, our team can take it from discovery to validated concept — typically reducing your R&D timeline by 70-85%.
Contact for Licensing Discussion